Lack of chemopreventive effects of ginger on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats

Food and Chemical Toxicology

Volumn 44, Issue 6, 2006, Pages 877-884

  Dias, M C ^a   Spinardi Barbisan, A L T ^a   Rodrigues, M A M ^a   de Camargo, J L V ^a   Teran E ^b   Barbisan, L F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Grupo CentroFlora   (Brazil)

Author keywords

Aberrant crypt foci; Chemoprevention; Colon carcinogenesis; Dimethylhydrazine; Ginger

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CHOLESTEROL; EDETIC ACID; GINGER EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOASSAY; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CHOLESTEROL BLOOD LEVEL; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; CRYPT CELL; DIET; GINGER; MALE; NONHUMAN; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE;

1,2-DIMETHYLHYDRAZINE; ANIMALS; APOPTOSIS; CARCINOGENS; CELL DIVISION; COLON; COLONIC NEOPLASMS; DIET; GINGER; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS; ZINGIBER OFFICINALE;

EID: 33645951999     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2005.11.015     Document Type: Article

References (46)

1. Agner A.R., Bazo A.P., Ribeiro L.R., and Salvadori D.M.F. DNA damage and aberrant crypt foci as putative biomarkers to evaluate the chemopreventive effect of annatto (Bixa orellana L.) in rat colon carcinogenesis. Mutation Research 582 (2005) 146-154
2. Bazo A.P., Rodrigues M.A.M., Sforcin J.M., de Camargo J.L.V., Ribeiro L.R., and Salvadori D.M.F. Protective action of propolis on the rat colon carcinogenesis. Teratogenesis, Carcinogenesis, and Mutagenesis 22 (2002) 183-194
3. Bird R.P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Letters 93 (1995) 55-71
4. Chang W.L., Chapkin R.S., and Lupton J.R. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis 18 (1997) 721-730
5. de Lima R.O., Bazo A.P., Said R.A., Sforcin J.M., Bankova V., Darros B.R., and Salvadori D.M.F. Modifying effect of propolis on dimethylhydrazine-induced DNA damage but not colonic aberrant crypt foci in rats. Environmental and Molecular Mutagenesis 45 (2005) 8-16
6. Einspahr J.G., Alberts D.S., Gapstur S.M., Bostick R.M., Emerson S.S., and Gerner E.W. Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials. Cancer Epidemiology Biomarkers and Prevention 6 (1997) 37-48
7. Gee J.M., Notrbom H.P., Polley A.C., and Johnson I.T. Increased induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats fed diets containing purified genistein or genistein-rich soy protein. Carcinogenesis 21 (2000) 2255-2259
8. Hardman W.E., Cameron I.L., Heitman D.W., and Contreras E. Demonstration of the need for end point validation of putative biomakers: failure of aberrant crypt foci to predict colon cancer incidence. Cancer Research 51 (1991) 6388-6392
9. Hsu S.M., Raine L., and Fanger N. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. Journal of Histochemistry and Cytochemistry 29 (1981) 557-580
10. Jackson P.E., O'Connor P.J., Cooper D.P., Marginson G.P., and Povey A.C. Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine. Carcinogenesis 24 (2003) 527-533
11. Jo W.-S., and Chung D.-C. Genetics hereditary colorectal cancer. Seminars in Oncology 23 (2005) 11-23
12. Katiyar S.K., Agarwal R., and Mukhtar H. Inhibition of tumor promotion in sencar skin by ethanol extract of Zingiber officinale rhizome. Cancer Research 56 (1996) 1023-1030
13. Kawamori T., Tanaka T., Hara A., Yamahara J., and Mori H. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in Fischer rats. Cancer Research 55 (1995) 1277-1282
14. Keum Y.-S., Kim J., Lee K.-H., Park K.-K., Surth Y.-J., Lee J.-M., Lee S.-S., Yoon J.-H., Joo S.-Y., Cha I.-H., and Yook J.-I. Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cells. Cancer Letters 177 (2002) 41-47
15. Langner E., Greifenberg S., and Gruenwald J. Ginger: history and use. Advances in Therapy 15 (1998) 25-44
16. Leal P.F., Braga M.E.M., Sato D.N., Carvalho J.E., Marques M.O.M., and Meireles M.A.A. Functional properties of spice extracts obtained via supercritical fluid extraction. Journal of Agricultural and Food Chemical 51 (2003) 2520-2525
17. Lee E., and Surth Y.-J. Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-gingerol and [6]-paradol. Cancer Letters 134 (1998) 163-168
18. Lieberman, D.A., Prindiville, S., Weiss, D.G., Willett, W., 2003. Va Cooperative Study Group 380. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. Jama 290, 2959-2967.
19. Mason J.B. Nutritional chemoprevention of colon cancer. Seminaries in Gastrointestinal Disease 13 (2002) 143-153
20. McLellan E.A., Medline A., and Bird R.P. Sequential analysis of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Research 51 (1991) 5270-5274
21. Mori M., Hata K., Yamada Y., Kuno T., and Hara A. Significance and role of early-lesions in experimental colorectal carcinogenesis. Chemico-Biological Interactions 155 (2005) 1-9
22. Park H.S., Goodland R., and Wright N.A. The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology. Cancer Research 57 (1997) 4507-4510
23. Park K.K., Chun K.S., Lee J.M., Lee S.S., and Surh Y.J. Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor carcinogenesis in ICR mice. Cancer Letters 129 (1998) 139-144
24. Penna S.C., Medeiros M.V., Aimbire F.S.C., Faria-Neto H.C.C., Sertié J.A.A., and Lopes-Martins R.A.B. Anti-inflammatory effect of the hydralcoholic extract of Zingiber officinale rhizomes on rat paw and skin edema. Phytomedicine 10 (2003) 381-385
25. Pereira M.A., Barnes L.H., Rassman V.L., Kelloff G.V., and Steele V.E. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 15 (1994) 1049-1054
26. Poten C.S., Li Y.Q., O'Connor P.J., and Winton D.J. A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel. Carcinogenesis 13 (1992) 2305-2312
27. Pretlow T.P., Barrow B.J., Ashton W.S., O'riordan M.A., Pretlow T.G., Incisek J.A., and Stellato T.A. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Research 51 (1991) 1564-1567
28. Rao C.V., Wang C.X., Simi B., Lubet R., Keloff G., Steele V., and Reddy B.S. Enhancement of experimental colon cancer by genistein. Cancer Research 57 (1997) 3717-3722
29. Risio M., Lipkin M., Newmark H., Yang K., Rossini F.P., Steele V.E., Boome C.W., and Kelloff G.J. Apoptosis and cell replication, and western-style diet-induced tumorigenesis in mouse colon. Cancer Research 56 (1996) 4910-4916
30. Rodrigues M.A.M., Silva L.A.G., Salvadori D.M.F., Camargo J.L.V., and Montenegro M.R. Aberrant crypt foci and colon cancer: comparison between a short- and medium term bioassay for colon medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Brazilian Journal of Medical and Biological Research 35 (2002) 351-355
31. Roncucci L., Stamp D., Medline A., Cullen J.B., and Bruce W.R. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Human Pathology 22 (1991) 287-294
32. Sharma I., Gusain D., and Dixit V.P. Hypolipidaemic and antiatherosclerotic effects of Zingiber officinale in cholesterol fed rabbits. Phytotherapy Research 10 (1996) 517-518
33. Srinivasan K., and Sambaiah K. The effect of spices on cholesterol 7α-hydroxylase activity and on serum and hepatic cholesterol levels in the rat. International Journal of Vitamin and Nutrition Research 61 (1991) 364-369
34. Steele V.E., Pereira M.A., Sigman C.C., and Kelloff G.J. Cancer chemoprevention agent development strategies for genistein. Journal of Nutrition 125 Suppl. 3 (1995) 713S-716S
35. Surh Y.-J. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food and Chemical Toxicology 40 (2002) 1091-1097
36. Surh Y.J., Park K.K., Chun K.S., Lee L.J., Lee E., and Lee S.S. Anti-tumor-promoting activities of selected pungent phenolic substances present in ginger. Journal of Environmental Pathology Toxicology and Oncology 18 (1997) 131-139
37. Surh Y.-J., Lee E., and Lee J.-M. Chemopreventive properties of some pungent ingredients present in red pepper and ginger. Mutation Research 402 (1998) 259-267
38. Takayama T., Miyanishi K., Hayashi T., Kukitsu T., Takanashi K., Ishiwatari H., Kogawa T., Abe T., and Niitsu Y. Aberrant crypt foci: detection, gene, abnormalities, and clinical usefulness. Clinical Gastroenterology and Hepatology 3 Suppl. 7 (2005) 42S-45S
39. Tanabe M., Chen Y.-D., Saito K.-I., and Kano Y. Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe. Chemical Pharmacology Bulletin 41 (1993) 710-713
40. Thiagarajan D.G., Bennink M.R., Bourquin L.D., and Kavas F.A. Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium. American Journal of Clinical Nutrition 68 Suppl. 6 (1998) 1394S-1399S
41. Thomson M., Al-Qattan K.K., Al-Sawan S.M., Alnaqeeb M.A., Khan I., and Ali M. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins, Leukotrienes and Essential Fatty Acids 67 (2002) 475-478
42. Wargovich M.J., Chen C., Jimenez A., Steele V.E., Velasco M., Stephens L.C., Price R., Gray K., and Kelloff G. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiology Biomarkers and Prevention 5 (1996) 355-360
43. Wijnands M.V., van Erk M.J., Doornbos R.P., Krul C.A., and Woutersen R.A. Do aberrant crypt foci have predictive value for the occurrence of colorectal tumors? Potential of gene expression profiling in tumors. Food and Chemical Toxicology 42 (2005) 1629-1639
44. Yamada Y., and Mori H. Pre-cancerous lesions of colorectal cancers in rodents: a new concept. Carcinogenesis 24 (2003) 1015-1019
45. Yoshimi N., Wang A., Morishita Y., Tanaka T., Sugie S., Kawai K., Yamahara J., and Mori H. Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats. Japanese Journal of Cancer Research 83 (1992) 1273-1278
46. Young H.Y., Luo Y.L., Cheng H.Y., Hsieh W.C., Liao J.C., and Peng W.H. Analgesic and anti-inflammatory activities of [6]-gingerol. Journal of Ethnopharmacology 96 (2005) 207-210